Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DOCN | Common Stock | Options Exercise | $300K | +53.5K | +1.7% | $5.61* | 3.19M | Jan 13, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DOCN | Stock Option (Right to buy) | Options Exercise | $0 | -53.5K | -1.53% | $0.00 | 3.45M | Jan 13, 2022 | Common Stock | 53.5K | $5.61 | Direct | F2 |
Id | Content |
---|---|
F1 | The amount reported includes shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt from reporting pursuant to Rule 16a-3(f)(1)(i)(B). |
F2 | One fourth of the shares underlying this option vested and became exercisable on August 13, 2020, and the remaining shares underlying this option vest in 36 equal monthly installments beginning on September 13, 2020, subject to the Reporting Person's continuous service with the Issuer on each such date. |